Birdwatch Note
2024-04-19 08:30:25 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
実際には勿論、既にとられており海外の研究同様に何度も公表されている事に注意が必要です。 ワクチンの重症予防効果はランダム化比較試験のメタ解析で確認され、 https://www.carenet.com/news/general/carenet/56042 海外のオミクロン期の観察研究のメタ解析でも示されているのは勿論のこと、↓ https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00409-1/fulltext 日本でも感染研から示され https://medical-tribune.co.jp/news/2023/0519556650/ 長崎大から示され(発症予防効果も同時に示されています) https://www3.nhk.or.jp/news/html/20230304/k10013998631000.html XBBワクチンでも既に国内の入院予防効果が報告済です↓ https://www.tm.nagasaki-u.ac.jp/versus/results/20240228.pdf 後遺症に関しては厚生労働省の研究班の19万人の住民の調査により感染前にワクチンを接種した人は接種していない人に比べて症状が続く割合がやや低かった事が発表されています↓ https://www3.nhk.or.jp/news/html/20230923/k10014204451000.html
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1781190185629417710
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1781238914675835004
- noteId - 1781238914675835004
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1713515425733
- tweetId - 1781190185629417710
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 実際には勿論、既にとられており海外の研究同様に何度も公表されている事に注意が必要です。 ワクチンの重症予防効果はランダム化比較試験のメタ解析で確認され、 https://www.carenet.com/news/general/carenet/56042 海外のオミクロン期の観察研究のメタ解析でも示されているのは勿論のこと、↓ https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00409-1/fulltext 日本でも感染研から示され https://medical-tribune.co.jp/news/2023/0519556650/ 長崎大から示され(発症予防効果も同時に示されています) https://www3.nhk.or.jp/news/html/20230304/k10013998631000.html XBBワクチンでも既に国内の入院予防効果が報告済です↓ https://www.tm.nagasaki-u.ac.jp/versus/results/20240228.pdf 後遺症に関しては厚生労働省の研究班の19万人の住民の調査により感染前にワクチンを接種した人は接種していない人に比べて症状が続く割合がやや低かった事が発表されています↓ https://www3.nhk.or.jp/news/html/20230923/k10014204451000.html
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-04-19 08:30:25 UTC (1713515425733) |
2024-04-19 13:22:18 UTC (1713532938377) |
CURRENTLY_RATED_HELPFUL | 2024-04-20 02:23:02 UTC (1713579782444) |
NEEDS_MORE_RATINGS | 2024-04-19 13:22:18 UTC (1713532938377) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-04-19 19:29:07 -0500 | Rating Details | |
2024-04-19 19:15:03 -0500 | Rating Details | |
2024-04-19 19:01:25 -0500 | Rating Details | |
2024-04-19 19:00:07 -0500 | Rating Details | |
2024-04-19 17:58:46 -0500 | Rating Details | |
2024-04-19 17:49:31 -0500 | Rating Details | |
2024-04-19 17:26:57 -0500 | Rating Details | |
2024-04-19 17:17:12 -0500 | Rating Details | |
2024-04-19 16:46:50 -0500 | Rating Details | |
2024-04-19 16:39:42 -0500 | Rating Details | |
2024-04-19 16:25:10 -0500 | Rating Details | |
2024-04-19 11:39:12 -0500 | Rating Details | |
2024-04-19 11:36:18 -0500 | Rating Details | |
2024-04-19 09:16:43 -0500 | Rating Details | |
2024-04-19 09:15:14 -0500 | Rating Details | |
2024-04-19 08:40:01 -0500 | Rating Details | |
2024-04-19 08:04:01 -0500 | Rating Details | |
2024-04-19 07:13:39 -0500 | Rating Details | |
2024-04-19 06:58:04 -0500 | Rating Details | |
2024-04-19 05:26:38 -0500 | Rating Details | |
2024-04-19 05:16:43 -0500 | Rating Details | |
2024-04-19 05:15:44 -0500 | Rating Details | |
2024-04-19 04:49:52 -0500 | Rating Details | |
2024-04-19 04:40:37 -0500 | Rating Details | |
2024-04-19 04:30:10 -0500 | Rating Details | |
2024-04-19 04:21:46 -0500 | Rating Details | |
2024-04-19 04:13:46 -0500 | Rating Details | |
2024-04-19 03:57:53 -0500 | Rating Details | |
2024-04-20 00:04:16 -0500 | Rating Details | |
2024-04-19 21:43:33 -0500 | Rating Details | |
2024-04-19 21:20:39 -0500 | Rating Details | |
2024-04-19 20:57:36 -0500 | Rating Details | |
2024-04-19 20:47:17 -0500 | Rating Details | |
2024-04-22 04:10:08 -0500 | Rating Details | |
2024-04-22 04:05:21 -0500 | Rating Details | |
2024-04-21 22:47:54 -0500 | Rating Details | |
2024-04-21 22:15:45 -0500 | Rating Details | |
2024-04-21 22:12:46 -0500 | Rating Details | |
2024-04-19 20:57:16 -0500 | Rating Details | |
2024-04-19 19:21:26 -0500 | Rating Details | |
2024-04-19 19:11:38 -0500 | Rating Details | |
2024-04-19 18:43:13 -0500 | Rating Details | |
2024-04-19 18:38:22 -0500 | Rating Details | |
2024-04-19 18:31:35 -0500 | Rating Details | |
2024-04-19 18:06:42 -0500 | Rating Details | |
2024-04-19 18:00:20 -0500 | Rating Details | |
2024-04-19 16:32:16 -0500 | Rating Details | |
2024-04-19 15:58:29 -0500 | Rating Details | |
2024-04-19 11:34:21 -0500 | Rating Details | |
2024-04-19 07:31:50 -0500 | Rating Details | |
2024-04-19 06:26:51 -0500 | Rating Details | |
2024-04-19 05:53:59 -0500 | Rating Details | |
2024-04-19 05:39:20 -0500 | Rating Details | |
2024-04-19 04:50:57 -0500 | Rating Details | |
2024-04-19 04:49:22 -0500 | Rating Details | |
2024-04-19 04:43:34 -0500 | Rating Details | |
2024-04-19 04:34:11 -0500 | Rating Details | |
2024-04-19 04:20:56 -0500 | Rating Details | |
2024-04-19 04:19:42 -0500 | Rating Details | |
2024-04-19 04:19:32 -0500 | Rating Details | |
2024-04-19 04:09:47 -0500 | Rating Details | |
2024-04-19 04:09:38 -0500 | Rating Details | |
2024-04-19 03:50:26 -0500 | Rating Details | |
2024-04-19 03:35:13 -0500 | Rating Details | |
2024-04-26 14:45:16 -0500 | Rating Details | |
2024-04-26 20:32:15 -0500 | Rating Details | |
2024-04-25 03:36:51 -0500 | Rating Details | |
2024-04-23 11:34:38 -0500 | Rating Details | |
2024-04-22 11:26:16 -0500 | Rating Details | |
2024-04-22 09:24:45 -0500 | Rating Details | |
2024-04-22 02:28:14 -0500 | Rating Details | |
2024-04-22 02:25:33 -0500 | Rating Details | |
2024-04-22 01:52:48 -0500 | Rating Details | |
2024-04-22 01:16:04 -0500 | Rating Details | |
2024-04-21 22:19:19 -0500 | Rating Details | |
2024-04-21 22:14:02 -0500 | Rating Details | |
2024-04-19 22:32:06 -0500 | Rating Details | |
2024-04-19 21:03:56 -0500 | Rating Details | |
2024-04-19 18:59:19 -0500 | Rating Details | |
2024-04-19 18:22:57 -0500 | Rating Details | |
2024-04-19 18:07:34 -0500 | Rating Details | |
2024-04-19 17:02:53 -0500 | Rating Details | |
2024-04-19 13:17:37 -0500 | Rating Details | |
2024-04-19 13:15:33 -0500 | Rating Details | |
2024-04-19 11:31:25 -0500 | Rating Details | |
2024-04-19 09:28:22 -0500 | Rating Details | |
2024-04-19 09:20:20 -0500 | Rating Details | |
2024-04-19 08:15:27 -0500 | Rating Details | |
2024-04-19 07:23:35 -0500 | Rating Details | |
2024-04-19 07:15:19 -0500 | Rating Details | |
2024-04-19 07:03:17 -0500 | Rating Details | |
2024-04-19 07:03:03 -0500 | Rating Details | |
2024-04-19 06:09:01 -0500 | Rating Details | |
2024-04-19 06:08:03 -0500 | Rating Details | |
2024-04-19 05:59:24 -0500 | Rating Details | |
2024-04-19 05:41:40 -0500 | Rating Details | |
2024-04-19 05:36:05 -0500 | Rating Details | |
2024-04-19 05:21:47 -0500 | Rating Details | |
2024-04-19 05:21:25 -0500 | Rating Details | |
2024-04-19 05:21:14 -0500 | Rating Details | |
2024-04-19 05:19:02 -0500 | Rating Details | |
2024-04-19 05:02:33 -0500 | Rating Details | |
2024-04-19 04:59:00 -0500 | Rating Details | |
2024-04-19 04:37:53 -0500 | Rating Details | |
2024-04-19 04:36:27 -0500 | Rating Details | |
2024-04-19 04:25:04 -0500 | Rating Details | |
2024-04-19 04:12:26 -0500 | Rating Details | |
2024-04-19 04:08:59 -0500 | Rating Details | |
2024-04-19 04:08:59 -0500 | Rating Details | |
2024-04-19 04:08:41 -0500 | Rating Details | |
2024-04-19 04:03:19 -0500 | Rating Details | |
2024-04-19 04:00:44 -0500 | Rating Details | |
2024-04-19 03:42:51 -0500 | Rating Details | |
2024-04-19 03:41:51 -0500 | Rating Details | |
2024-04-25 02:19:44 -0500 | Rating Details | |
2024-04-23 19:26:17 -0500 | Rating Details | |
2024-04-22 19:11:12 -0500 | Rating Details | |
2024-04-22 01:41:53 -0500 | Rating Details | |
2024-04-21 23:18:13 -0500 | Rating Details | |
2024-04-21 22:28:50 -0500 | Rating Details | |
2024-04-21 22:18:33 -0500 | Rating Details | |
2024-04-21 22:16:26 -0500 | Rating Details | |
2024-04-21 21:33:21 -0500 | Rating Details |